drugset
drugset / Trial / NCT02790736

Brief Intervention to Reduce Fear of Public Speaking

NCT02790736 ↗

Phase 4 Terminated 6 enrolled New York State Psychiatric Institute
RandomizedParallel-groupTriple-blindOther

Summary

The study will test the efficacy of propranolol or placebo, administered after retrieval of a previously acquired public speaking fear, in reducing fear and avoidance of public speaking.

Timeline

Start
2016-06
Primary completion
2020-10-30
Completion
2020-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule 40 mg —

Indications

social phobia